Linked Life Data

9660598

Source:http://linkedlifedata.com/resource/pubmed/id/9660598

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9109
pubmed:dateCreated
1998-7-24
pubmed:abstractText
In France, when a new medical technology is to be applied experimentally to human beings, it must adhere to the principles stipulated by the Huriet-Sérusclat law on biomedical research. This law requires that the validation of a protocol applicable to human beings, with its corollary protection and information dimensions, is first submitted to a research committee, known as a Consultative Committee Protecting Persons in Biomedical Research (CCPPRB). We aimed to survey the competence of these committees in biotechnology, and whether or not intracytoplasmic sperm injection (ICSI) had been considered by the committees as being an innovative treatment.
pubmed:keyword
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0140-6736
pubmed:author
pubmed:issnType
Print
pubmed:day
11
pubmed:volume
351
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1121-3
pubmed:dateRevised
2004-11-18
pubmed:meshHeading
pubmed:year
1998
pubmed:articleTitle
Analysis of a survey of 36 French research committees on intracytoplasmic sperm injection.
pubmed:affiliation
Laboratoire d'Ethique Médicale et de Sante Publiqué, Faculté de Médecine Necker, Paris, France.
pubmed:publicationType
Journal Article